The FDA Just Rejected a Bid for MDMA to Treat PTSD

The agency has asked drugmaker Lykos Therapeutics to run an additional study on the use of the psychedelic drug in patients with post-traumatic stress disorder, pushing back its next proposal by years.

Aug 10, 2024 - 16:00
The FDA Just Rejected a Bid for MDMA to Treat PTSD
The agency has asked drugmaker Lykos Therapeutics to run an additional study on the use of the psychedelic drug in patients with post-traumatic stress disorder, pushing back its next proposal by years.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow